These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
423 related items for PubMed ID: 26842926
1. Immunization of stromal cell targeting fibroblast activation protein providing immunotherapy to breast cancer mouse model. Meng M, Wang W, Yan J, Tan J, Liao L, Shi J, Wei C, Xie Y, Jin X, Yang L, Jin Q, Zhu H, Tan W, Yang F, Hou Z. Tumour Biol; 2016 Aug; 37(8):10317-27. PubMed ID: 26842926 [Abstract] [Full Text] [Related]
2. Improvement of anti-tumor immunity of fibroblast activation protein α based vaccines by combination with cyclophosphamide in a murine model of breast cancer. Xia Q, Zhang FF, Geng F, Liu CL, Wang YQ, Xu P, Lu ZZ, Xie Y, Wu H, Chen Y, Zhang Y, Kong W, Yu XH, Zhang HH. Cell Immunol; 2016 Dec; 310():89-98. PubMed ID: 27545090 [Abstract] [Full Text] [Related]
3. Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice. Duperret EK, Trautz A, Ammons D, Perales-Puchalt A, Wise MC, Yan J, Reed C, Weiner DB. Clin Cancer Res; 2018 Mar 01; 24(5):1190-1201. PubMed ID: 29269377 [Abstract] [Full Text] [Related]
8. Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia. Tran E, Chinnasamy D, Yu Z, Morgan RA, Lee CC, Restifo NP, Rosenberg SA. J Exp Med; 2013 Jun 03; 210(6):1125-35. PubMed ID: 23712432 [Abstract] [Full Text] [Related]
9. A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice. Fang J, Xiao L, Joo KI, Liu Y, Zhang C, Liu S, Conti PS, Li Z, Wang P. Int J Cancer; 2016 Feb 15; 138(4):1013-23. PubMed ID: 26334777 [Abstract] [Full Text] [Related]
10. Anti-tumor effects of DNA vaccine targeting human fibroblast activation protein α by producing specific immune responses and altering tumor microenvironment in the 4T1 murine breast cancer model. Xia Q, Zhang FF, Geng F, Liu CL, Xu P, Lu ZZ, Yu B, Wu H, Wu JX, Zhang HH, Kong W, Yu XH. Cancer Immunol Immunother; 2016 May 15; 65(5):613-24. PubMed ID: 27020681 [Abstract] [Full Text] [Related]
17. Cyclophosphamide enhances anti-tumor effects of a fibroblast activation protein α-based DNA vaccine in tumor-bearing mice with murine breast carcinoma. Xia Q, Geng F, Zhang FF, Liu CL, Xu P, Lu ZZ, Xie Y, Sun B, Wu H, Yu B, Kong W, Yu XH, Zhang HH. Immunopharmacol Immunotoxicol; 2017 Feb 15; 39(1):37-44. PubMed ID: 28004985 [Abstract] [Full Text] [Related]
18. Protein Nanocage Mediated Fibroblast-Activation Protein Targeted Photoimmunotherapy To Enhance Cytotoxic T Cell Infiltration and Tumor Control. Zhen Z, Tang W, Wang M, Zhou S, Wang H, Wu Z, Hao Z, Li Z, Liu L, Xie J. Nano Lett; 2017 Feb 08; 17(2):862-869. PubMed ID: 28027646 [Abstract] [Full Text] [Related]
19. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells. Lee HO, Mullins SR, Franco-Barraza J, Valianou M, Cukierman E, Cheng JD. BMC Cancer; 2011 Jun 13; 11():245. PubMed ID: 21668992 [Abstract] [Full Text] [Related]
20. FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling. Yang X, Lin Y, Shi Y, Li B, Liu W, Yin W, Dang Y, Chu Y, Fan J, He R. Cancer Res; 2016 Jul 15; 76(14):4124-35. PubMed ID: 27216177 [Abstract] [Full Text] [Related] Page: [Next] [New Search]